This article was reviewed by Mike Bohl, MD. If you’ve been using a GLP-1 such as semaglutide, then you’ve likely experienced the powerful effects of this weight loss medication. You’re ...

The drug — the brand name for the GLP-1 agonist semaglutide — “significantly reduced weekly alcohol craving,” according to a study published Wednesday, Feb. 12, in the Journal of the ...

The participants were divided into two groups, with half receiving weekly low-dose injections of semaglutide (Ozempic and Wegovy), a GLP-1 agonist, and the other half getting a placebo shot.

Half received semaglutide, a type of GLP-1 receptor agonist, while the other half received no treatment. Over the nine-week trial, participants taking semaglutide started at a dose of 0.25 mg per ...

"Adherence improves when treatment integrates easily into patients’ lives," explains Adam McBride, Eden’s CEO. Eden’s digital ...

Semaglutide is in a class called glucagon-like peptide-1 (GLP-1) receptor agonists ... The recommended maintenance dose of Wegovy is 2.4 milligrams (mg) weekly. But not everyone will need such ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss ... two lowest clinical doses of semaglutide, whereas doses for weight reduction reach 2.4 mg/week," the researchers noted ...